Peter G Traber - Net Worth and Insider Trading
Peter G Traber Net Worth
The estimated net worth of Peter G Traber is at least $687,032 dollars as of 2024-04-27. Peter G Traber is the President & CEO of Galectin Therapeutics Inc and owns about 107,333 shares of Galectin Therapeutics Inc (GALT) stock worth over $370,299. Peter G Traber is also the Chief Medical Officer of Cartesian Therapeutics Inc and owns about 15,061 shares of Cartesian Therapeutics Inc (RNAC) stock worth over $316,733. Details can be seen in Peter G Traber's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Peter G Traber has not made any transactions after 2023-09-25 and currently still holds the listed stock(s).
Transaction Summary of Peter G Traber
Peter G Traber Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Peter G Traber owns 3 companies in total, including Cartesian Therapeutics Inc (RNAC) , Lisata Therapeutics Inc (LSTA) , and Galectin Therapeutics Inc (GALT) .
Click here to see the complete history of Peter G Traber’s form 4 insider trades.
Insider Ownership Summary of Peter G Traber
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RNAC | Cartesian Therapeutics Inc | 2023-09-25 | Chief Medical Officer |
| LSTA | Lisata Therapeutics Inc | 2015-01-22 | director |
| GALT | Galectin Therapeutics Inc | 2018-06-13 | director & President and CEO |
Peter G Traber Latest Holdings Summary
Peter G Traber currently owns a total of 2 stocks. Among these stocks, Peter G Traber owns 107,333 shares of Galectin Therapeutics Inc (GALT) as of June 13, 2018, with a value of $370,299 and a weighting of 53.9%. Peter G Traber also owns 15,061 shares of Cartesian Therapeutics Inc (RNAC) as of September 25, 2023, with a value of $316,733 and a weighting of 46.1%.
Latest Holdings of Peter G Traber
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GALT | Galectin Therapeutics Inc | 2018-06-13 | 107,333 | 3.45 | 370,299 |
| RNAC | Cartesian Therapeutics Inc | 2023-09-25 | 15,061 | 21.03 | 316,733 |
Holding Weightings of Peter G Traber
Peter G Traber Form 4 Trading Tracker
According to the SEC Form 4 filings, Peter G Traber has made a total of 0 transactions in Galectin Therapeutics Inc (GALT) over the past 5 years. The most-recent trade in Galectin Therapeutics Inc is the sale of 100,000 shares on June 13, 2018, which brought Peter G Traber around $751,000.
According to the SEC Form 4 filings, Peter G Traber has made a total of 7 transactions in Cartesian Therapeutics Inc (RNAC) over the past 5 years, including 3 buys and 4 sells. The most-recent trade in Cartesian Therapeutics Inc is the sale of 23 shares on September 25, 2023, which brought Peter G Traber around $747.
Insider Trading History of Peter G Traber
- 1
Peter G Traber Trading Performance
GuruFocus tracks the stock performance after each of Peter G Traber's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peter G Traber is 33.71%. GuruFocus also compares Peter G Traber's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peter G Traber within 3 months outperforms 9 times out of 14 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Peter G Traber's insider trading performs compared to the benchmark.
Performance of Peter G Traber
Average Return
59.9%
Outperforming Transactions
23%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 9.21 | 33.71 | 26.32 | 59.9 | -18.62 | -20.67 |
| Relative Return to S&P 500(%) | 9.04 | 31.06 | 19.35 | 49.45 | -26.46 | -29.76 |
Peter G Traber Ownership Network
Ownership Network List of Peter G Traber
Ownership Network Relation of Peter G Traber
Peter G Traber Owned Company Details
What does Cartesian Therapeutics Inc do?
Who are the key executives at Cartesian Therapeutics Inc?
Peter G Traber is the Chief Medical Officer of Cartesian Therapeutics Inc. Other key executives at Cartesian Therapeutics Inc include director & President & CEO Carsten Brunn , Chief Scientific Officer Takashi Kei Kishimoto , and COO and SVP & R&D Lloyd P. Johnston .
Cartesian Therapeutics Inc (RNAC) Insider Trades Summary
Over the past 18 months, Peter G Traber made 2 insider transaction in Cartesian Therapeutics Inc (RNAC) with a net sale of 12,349. Other recent insider transactions involving Cartesian Therapeutics Inc (RNAC) include a net purchase of 1,223,316 shares made by Timothy A Springer , a net sale of 48,524 shares made by Carsten Brunn , and a net sale of 9,784 shares made by Takashi Kei Kishimoto .
In summary, during the past 3 months, insiders sold 0 shares of Cartesian Therapeutics Inc (RNAC) in total and bought 40,777 shares, with a net purchase of 40,777 shares. During the past 18 months, 2,681 shares of Cartesian Therapeutics Inc (RNAC) were sold and 40,777 shares were bought by its insiders, resulting in a net purchase of 38,096 shares.
Cartesian Therapeutics Inc (RNAC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cartesian Therapeutics Inc Insider Transactions
Peter G Traber Mailing Address
Above is the net worth, insider trading, and ownership report for Peter G Traber. You might contact Peter G Traber via mailing address: 430 Thamer Lane, Houston Tx 77025.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
